Haematology 4 - Chronic myeloproliferative neoplasms Flashcards

1
Q

How should pseudopolychthaemia and polycythaemia vera be differentiated?

A

Isotype dilution method

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Recall 3 causes of pseudopolycythaemia

A

Alcohol
Obesity
Diuretics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Causes of secondary polycythaemia

A

(non-malignant)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Classification of myeloproliferative disorders

A

a) philadelphia negative
- essential thrombocythaemia
- polycythaemia vera
- primary myelofibrosis
b) philadelhpia positive
- CML

**proliferation increased, differentiation normal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the most common gene that is mutated in philadelphia negative MPDs?

A

JAK2- this is a tyrosine kinase

(other genes: calreticulin, MPL)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the normal role of janus kinases?

A

They activate the STAT pathway, which promotes cell growth and replication

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How does JAK2 mutation cause uncontrollable replication?

A

No longer need growth factor to activate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

In polycythaemia vera, what else will be abnormal on the FBC other than red cell count?

A

Pronounced thrombophilia and slight increase in granulocyte count

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Recall some symptoms of polycythaemia vera

A

Due to hyperviscosity:
- Headaches
- visual disturbances
- dyspnoea
Due to increased histamine release:
- peptic ulcer
- aquagenic pruritis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Recall four clinical findings in polycythaemia vera

A

Plethora
Erythromelalgia (red, painful extremities)
Gout
Retinal vein engorgement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the expected level of erythropoietin in polycythaemia vera?

A

Low

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What mutation is present in all patients with polycythaemia vera?

A

JAK2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Recall 3 ways in which polycythaemia vera can be treated

A
  1. Venesection
  2. Cytoreductive therapy eg hydroxycarbamide
  3. Aspirin to reduce thrombosis risk
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is idiopathic erythrocytosis?

A

An isolated erythrocytosis with low EPO, where JAK2 V617 mutation is absent (although JAK mutation in exon 12 may be present)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How should idiopathic erythrocytosis be treated?

A

Venesection only

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How is essential thrombocytothaemia defined?

A

Chronic myeloproliferative neoplasm with a sustained thrombocytosis > 600 x 10^9/L

17
Q

Which age group is most at risk of essential thrombocytothaemia?

A

Bimodal:
Small peak at 30y (M=F)
Larger peak at 55y (F>M)

18
Q

How does ET present?

A
  • most likely an incidental finding
  • or can present with clinical features
    a) thrombosis- venous or arterial
    b) bleeding - mucous membrane and cutaneous **bc of abormal quality of platelets

Headaches, dizziness, visual disturbance

Modest splenomegaly

investigations

  • raised platelet count
  • blood film: large platelets and megakaryocyte fragments
  • increased BM megakaryocytes (not reactive)
19
Q

Is there a JAK2 mutation in essential thrombocytothaemia?

A

Yes in 50%

20
Q

What is the best treatment for essential thrombocytothaemia?

A

Hydroxycarbamide to reduce platelet count

Aspirin to reduce risk of thrombosis

and anagrelide- reduce formation of platelets form megakaryocytes

21
Q

Blood film and trephine biopsy in primary myelofibrosis

A

Also blood counts:

  • high platelet count (you get increased production of abnormal platelets–>pushing out other cells)
  • high LDH and high uric acid - reflecting increased RBC turnover
22
Q

Which condition is “tear drop poikilocytosis” pathognemonic of?

A

Myelofibrosis

23
Q

Recall 2 signs of myelofibrosis

A
  1. Massive spleen - (and maybe hepatomegaly)

As bone marrow is fibrosed you get extramedullary haematopoiesis

  1. Anaemia (leukoerythroblastic anaemia)

**can also present with budd chiari syndrome (occlusion of the hepatic vein)

24
Q

Prognosis of primary myelofibrosis

and treatment options?

A

BAD. worse than other philadelhpia negative MPDs

Tx: mainly supportive.

25
What is the best treatment for myelofibrosis?
Ruxolotinib - a JAK2 inhibitor
26
Even though chronic MPDs are "less deadly", what is a major risk?
They can tranform into acute leukaemias
27
How does CML present?
\*\*raised cell counts \*\*even though you have thrombocytosis, you can present with bleeding or clotting as the platelets are dysfunctional
28
FBC and blood film features of CML
- leucocytosis (predominantly due to granulocytes) - biphasic peak: neutrophilia and myelocytes - basophils raised as well - \<5% myeloblasts (unelss in blast crisis) - raised (or upper normal) platelet count- contrast with acute leukaemia Triad: leukocytosis, basophilia, neutrophilia - think CML!! (you also see a thrombocytosis
29
Genetics of philadelphia positvie MPD
BCR-ABL1 fusion gene positive Translocation of chromosome 9 and 22
30
How do you diagnose and monitor CML?
RT-PCR is most accurate
31
Clinical phases of CML
Accelerated phase: 10-19% blasts Blast crisis: \>20% blasts
32
What is the target of imatinib? Why is imatinib not 100% successful?
Mutated tyrosine kinase (by BCR-ABL gene) Not 100% successful because you can get resistance to treatment or disease may progress to blast crisis which evades treatment
33
Which 2 haematological cancers cause massive hepatosplenomegaly with no lymphadenopathy?
1. CML 2. myelofibrosis \*both examples of MPDs!! (because of extramedullary haematopoiesis) (if you have lymphadenopathy, it's a lymphoid problem)
34
What does low leukocyte alkaline phosphatase suggest?
CML
35
How to classify myeloproliferative disorders?
36
what two conditions can MPNs transform into?
myelofibrosis or acute luekaemia
37
38
What causes myelofibrosis?
can be idiopathic or can progress from other MPNs